P
I
3K
Ak
t
ME
K
K
3
P
K
C
8
P
I3
K
IKKα
IKKα
IKKβ
PKCβ
PKCζ
IKKα/β
GSK-3β
IκBα
NF-κB2
P50/52
NF-κB2
P52
NF-κB2
P52
NF-κB2
P50
NF-κB2
p100
HDA
C
A
T
M
NF-κB2
p100
NF-κB2
p100
IKKγ
NEMO
p38 MAPK
TNF
R
I
P
NI
K
R
I
PK1
TR
AD
D
PLC γ2
PLC γ2
M
SK
1
R
e
l
B
R
e
l
B
R
e
l
B
P
K
R
P65/RelA
P65/RelA
Growth Factors
Ag-MHC
Ag
LT, CD40L,
BAFF/BLys
Inflammation
Immune Regulation
Survival
Proliferation
Lymphogenesis
B Cell Maturation
P65/RelA
UV
Pan-IκB/IKK Inhibitors
Bardoxolone Methyl
IKK-16
Selective IκB/IKK Inhibitors
MRT67307 (IKKϵ)
IMD 0354 (IKKβ)
TPCA-1 (IKK-2)
TNF-alpha Inhibitors
Pomalidomide
Lenalidomide
Pan-HDAC Inhibitors
Vorinostat
Panobinostat
Trichostatin A
Belinostat
Selective HDAC Inhibitors
RGFP966 (HDAC3)
Tubastatin A (HDAC6)
PCI-34051 (HDAC8)
NF-κB Inhibitors
BAY 11-7082
JSH-23
QNZ
SC75741
Pyrrolidinedithiocarbamate
P
Growth Factors
Inflammation
Immune Regulation
Survival
Proliferation
Lymphogenesis B Cell Maturation
UV
{{ board.text }}
{{ board.text }}
{{ board.text }}
{{ board.text }}
LT, CD40L,
BAFF/BLys
{{ board.text }}
{{ board.text1 }}
{{ board.text2 }}
{{ group.title }}
{{ text.text }}
{{ button.text }}
{{ button.text1 }}
{{ button.text2 }}
{{ group.title }}
{{ text.text }}
Notes:
1:Clickable
2:Unclickable